JP2021038394A5
(https= )
2022-01-06
CA2445306A1
(en )
2002-11-07
Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
JP2008505932A5
(https= )
2008-08-28
CA2281929A1
(en )
1998-08-27
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
CA2431068A1
(en )
2002-07-04
Crystalline forms of atorvastatin
CA2462453A1
(en )
2003-04-10
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
WO2003014079A8
(en )
2003-11-20
Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
EP2085391A3
(en )
2010-08-18
Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
NO174772C
(no )
1994-07-06
Analogifremgangsmåte ved fremstilling av terapeutisk aktive piperazinylderivater
JP2007533722A5
(https= )
2008-06-19
JP2003535128A5
(https= )
2010-06-03
WO2003014080A3
(en )
2003-11-06
Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
JP2024146103A5
(https= )
2026-04-03
JPWO2023167306A5
(https= )
2024-11-19
WO2001078648A3
(en )
2003-12-18
6-methylnicotinamide derivatives as antiviral agents
JP2004525178A5
(https= )
2005-12-22
CA2281892A1
(en )
1998-09-11
Processes for preparing pesticidal intermediates
JP2020189856A5
(https= )
2023-05-08
JPWO2021108298A5
(https= )
2023-09-19
JP2002508338A5
(https= )
2006-01-26
JP2024111007A5
(https= )
2024-08-23
WO2003048153A8
(en )
2004-06-03
Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
JPWO2021025047A5
(https= )
2022-04-21
JP2001294524A5
(https= )
2007-05-24
JP2002527470A5
(https= )
2005-08-25